• Home
  • NEW DAY MEDICINE
  • 4 (66) 2024
  • 34 -4 (66) 2024 - Sharipova Barno Ergashevna - CHANGES IN THE HISIOARCHITECTONICS OF THE PANCREAS ASSOCIATED WITH COVID-19 INFECTION

34 -4 (66) 2024 - Sharipova Barno Ergashevna - CHANGES IN THE HISIOARCHITECTONICS OF THE PANCREAS ASSOCIATED WITH COVID-19 INFECTION

CHANGES IN THE HISIOARCHITECTONICS OF THE PANCREAS ASSOCIATED WITH COVID-19 INFECTION

Sharipova Barno Ergashevna Tashkent Medical Academy

Resume

The peculiarity of changes in the histioarchitecture of the pancreas during Covid-19 infection is that with Covid-19 there is a sharp increase in the permeability of the vascular wall, the occurrence of interstitial edema and the erasure of all components of the gland tissue, the shape of the cells changes as a result of interstitial swelling, the glands are compressed in the form of a circle, the islets of Langerhans acquired an oval and ganglion-shaped shape, while homogeneous tumors appeared around the glandular ducts and vessels, the sudden development of intermediate tumors in this area and the retention of glandular secretions in the synthesized areas. , i.e. in the cavity of the acinar glands, turned out to be hypercellular.

Keywords:pancreas, COVID-19, necrobiosis, pathomorphology, pancreatitis.

First page

197

Last page

202

For citation: Sharipova Barno Ergashevna - CHANGES IN THE HISIOARCHITECTONICS OF THE PANCREAS ASSOCIATED WITH COVID-19 INFECTION//New Day in Medicine 4(66)2024 197-202 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Correia de Sá T, Soares C, Rocha M. Acute pancreatitis and COVID-19: A literature review // World J Gastrointest Surg. 2021 Jun 27;13(6):574-584
  2. Jabłońska B, Olakowski M, Mrowiec S. Association between acute pancreatitis and COVID-19 infection: What do we know? // World J Gastrointest Surg. 2021 Jun 27;13(6):548-562.
  3. Kusmartseva I, Wu W, Syed F, Van Der Heide V. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19. // Cell Metab. 2020 Dec 1;32(6):1041-1051
  4. Coate KC, Cha J, Shrestha S, Wang W. et al. SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells. // Cell Metab. 2020 Dec 1;32(6):1028-1040.e4.
  5. Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. // AIMS Public Health. 2021 Oct 26;8(4):720-742.
  6. Goyal H, Kopel J, Ristić B, Perisetti A, Anastasiou J, Chandan S, Tharian B, Inamdar S. The pancreas and COVID-19: a clinical conundrum. // Am J Transl Res. 2021 Oct 15;13(10):11004-11013
  7. Pandanaboyana S, Moir J, Leeds JS, Oppong K, Kanwar A. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. // Gut. 2021 Jun;70(6):1061-1069.
  8. Bacaksız F, Ebik B, Ekin N, Kılıc J. Pancreatic damage in COVID-19: Why? How? // Int J Clin Pract. 2021 Oct;75(10):e14692.
  9. Furong L, Xin Long BZ, Wanguang ZXC, Zhanguo Z. ACE2 expression in pancreas may cause pancreatic damage after SARS‐CoV‐2 infection. // Clin Gastroenterol Hepatol. 2020;18:2128‐2130.e2
  10. Bruno G, Fabrizio C, Santoro CR, Buccoliero GB. Pancreatic injury in the course of coronavirus disease 2019 (COVID‐19): a not‐so‐rare occurrence. // J Med Virol. 2021;93:74–75.
  11. Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID‐19: a post‐mortem study. // Lancet Microbe. 2020;1:e245‐e253
  12. Cheung S, Delgado Fuentes A, Fetterman AD. Recurrent acute pancreatitis in a patient with COVID‐19 infection. // Am J Case Rep. 2020;21:e9270.
  13. Furong L, Xin Long BZ, Wanguang ZXC, Zhanguo Z. ACE2 expression in pancreas may cause pancreatic damage after SARS‐CoV‐2 infection. // Clin Gastroenterol Hepatol. 2020;18:2128‐2130.e2.
  14. Steenblock C, Richter S, Berger I, Barovic M, Schmid J, Schubert U. Viral infiltration of pancreatic islets in patients with COVID-19 // Nat Commun. 2021 Jun 10;12(1):3534.
  15. Sun DW, Zhang D, Tian RH, Li Y, Wang YS, Cao J, Tang Y, Zhang N, Zan T, Gao L, Huang YZ, Cui CL, Wang DX, Zheng Y, Lv GY. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? // Clin Chim Acta. 2020 Sep;508:122-129
  16. Thaweerat W. Current evidence on pancreatic involvement in SARS-CoV-2 infection. // Pancreatology. 2020 Jul;20(5):1013-1014.
  17. Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. // Acta Diabetol. 2010 Sep;47(3):193-9
  18. Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. // J Virol. 2014 Jan;88(2):1293-307
  19. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. // J Pathol. 2004 Jun;203(2):631-7
  20. Grusova G, Bruha R, Bircakova B, Novak M, Lambert L, Michalek P, Tomas G, Burgetova A. Pancreatic Injury in Patients with SARS-Cov-2 (COVID-19) Infection: A Retrospective Analysis of CT Findings. // Gastroenterol Res Pract. 2021 Oct 31;2021:5390337

    file

    download